Unknown

Dataset Information

0

18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.


ABSTRACT: Alveolar rhabdomyosarcoma (ARMS) and embryonal rhabdomyosarcoma (ERMS) are among the most common and most treatment resistant soft tissue sarcomas of childhood. Here, we evaluated the potential of (18)F-Fluorodeoxyglucose (FDG) as a marker of therapeutic response to picropodophyllin (PPP), an IGF1R inhibitor, in a conditional mouse model of ARMS and a conditional model of ERMS/undifferentiated pleomorphic sarcoma (UPS).Primary tumor cell cultures from Myf6Cre,Pax3:Fkhr,p53 and Pax7CreER,Ptch1,p53 conditional models of ARMS and ERMS/UPS were found to be highly sensitive to PPP (IC(50) values 150 and 200 nM, respectively). Animals of each model were then treated with 80 mg/kg/day PPP by intraperitoneal injection for 12 days and imaged by (18)F-FDG microPET.Tumor volumes on day 4 for PPP-treated ARMS and ERMS mice were lower than untreated control mouse tumor volumes, although treated tumors were larger than day 0. However, tumor FDG uptake was significantly reduced on day 4 for PPP-treated mice compared to pretreatment baseline or untreated control mice on day 4 (P < 0.05). Nevertheless, by day 12 tumor volumes and FDG uptake for treated mice had increased significantly, indicating rapidly evolving resistance to therapy.(18)F-FDG PET imaging is a potential imaging biomarker of molecular susceptibility to targeted agents early in treatment for this aggressive form of sarcoma, but may find best use serially for Phase I/II studies where chemotherapy and targeted agents are combined to cytoreduce tumors and abrogate Igf1r inhibitor resistance.

SUBMITTER: Soundararajan A 

PROVIDER: S-EPMC3924883 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.

Soundararajan Anuradha A   Abraham Jinu J   Nelon Laura D LD   Prajapati Suresh I SI   Zarzabal Lee Ann LA   Michalek Joel E JE   McHardy Stanton F SF   Hawkins Douglas S DS   Malempati Suman S   Keller Charles C  

Pediatric blood & cancer 20120111 3


<h4>Background</h4>Alveolar rhabdomyosarcoma (ARMS) and embryonal rhabdomyosarcoma (ERMS) are among the most common and most treatment resistant soft tissue sarcomas of childhood. Here, we evaluated the potential of (18)F-Fluorodeoxyglucose (FDG) as a marker of therapeutic response to picropodophyllin (PPP), an IGF1R inhibitor, in a conditional mouse model of ARMS and a conditional model of ERMS/undifferentiated pleomorphic sarcoma (UPS).<h4>Procedure</h4>Primary tumor cell cultures from Myf6Cre  ...[more]

Similar Datasets

| S-EPMC4161128 | biostudies-literature
| S-EPMC4109806 | biostudies-literature
| S-EPMC9132804 | biostudies-literature
| S-EPMC6459603 | biostudies-literature
2021-05-31 | GSE175816 | GEO
| S-EPMC5577626 | biostudies-literature
2019-12-31 | GSE142775 | GEO
| S-EPMC7667493 | biostudies-literature
| S-EPMC2644405 | biostudies-literature
| S-EPMC3419450 | biostudies-other